BIONIZBIONIZ

• About Us
  • Management
  • Board of Directors
  • Medical, Scientific Advisors

   
• Technology
  • Lead Program: Common-Gamma Receptor Antagonists

   
• Pipeline & Disease Focus
  • Lead Indication: HAM/TSP
  • Other Assets / Indications

   
• Investors & News Room
  • Press Release / Media
  • Events

   
• Contact Us